Neurotrophic keratopathy: current challenges and future prospects.
NaPier E, Camacho M, McDevitt TF, Sweeney AR.
NaPier E, et al.
Ann Med. 2022 Dec;54(1):666-673. doi: 10.1080/07853890.2022.2045035.
Ann Med. 2022.
PMID: 35243932
Free PMC article.
Review.
Stage 2 treatment can involve therapeutic contact lenses, topical autologous or allogenic serum, tarsorrhaphy, botulinum toxin injections, and possibly anti-inflammatory medications. ...New therapies, such as matrix regenerating therapy, plasma rich in growth factors, Thym …
Stage 2 treatment can involve therapeutic contact lenses, topical autologous or allogenic serum, tarsorrhaphy, botulinum toxin inject …